Gsk Plc ADR (GSK)

Feb 19, 2025, 12:13 PM EST - 3 days ago

Canada purchases 500,000 doses of GSK's vaccine for bird flu

Feb 18, 2025, 2:21 AM EST - 4 days ago

GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'

Feb 17, 2025, 11:30 AM EST - 5 days ago

Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors

Feb 17, 2025, 7:00 AM EST - 5 days ago

PENMENVY, GSK's 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY

Feb 14, 2025, 9:37 PM EST - 7 days ago

US FDA approves GSK's combo meningococcal vaccine

Feb 14, 2025, 12:20 PM EST - 8 days ago

Hedge Fund Citadel takes short position in GSK, FT reports

Feb 14, 2025, 5:46 AM EST - 8 days ago

India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs

Feb 11, 2025, 12:27 PM EST - 11 days ago

Deadline Approaching: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Law Offices of Howard G.

Feb 11, 2025, 12:10 PM EST - 11 days ago

Law Offices of Frank R. Cruz Encourages GSK plc.

Feb 7, 2025, 12:00 PM EST - 15 days ago

Law Offices of Howard G. Smith Encourages GSK plc.

Feb 6, 2025, 12:00 PM EST - 16 days ago

Securities Fraud Investigation Into GSK plc. (GSK) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Feb 6, 2025, 8:00 AM EST - 16 days ago

GSK Reported Strong Earnings, So I Reiterate My Strong Buy

Feb 6, 2025, 4:02 AM EST - 16 days ago

GSK Tech Ecosystem Profile - Digital Transformation Strategies and Innovation Programs

Feb 5, 2025, 5:00 PM EST - 17 days ago

GSK plc. (GSK) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Feb 5, 2025, 4:17 PM EST - 17 days ago

Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Large Losses to Contact the Firm for Information About Their Rights

Feb 5, 2025, 3:16 PM EST - 17 days ago

Securities Fraud Investigation Into GSK plc. (GSK) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R.

Feb 5, 2025, 12:26 PM EST - 17 days ago

GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan

Feb 5, 2025, 11:52 AM EST - 17 days ago

GSK plc (GSK) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 8:05 AM EST - 17 days ago

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion

Feb 5, 2025, 4:38 AM EST - 17 days ago

GSK shares surge around 6% as drugmaker raises sales target and boosts dividends

Feb 5, 2025, 2:17 AM EST - 17 days ago

GSK beats Q4 earnings estimates, lifts 2031 sales target

Feb 4, 2025, 11:50 AM EST - 18 days ago

Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary

BNTX MRNA NVAX PFE

Jan 27, 2025, 5:12 AM EST - 26 days ago

Influenza Vaccines Market Analysis 2025-2032: GlaxoSmithKline's Influenza Vaccines Sales Declined in 2024, Driven by Competitive Pressure and Volume Phasing in the US and Lower Demand

Jan 21, 2025, 2:35 PM EST - 4 weeks ago

Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

ITCI JNJ LLY NVO PFE

Jan 14, 2025, 6:13 PM EST - 5 weeks ago

Hallucinations in AI: How GSK is addressing a critical problem in drug development

Jan 14, 2025, 4:31 PM EST - 5 weeks ago

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

AMZN LLY DXCM JNJ MRNA NVDA TDOC

Jan 14, 2025, 12:56 PM EST - 5 weeks ago

GSK plc (GSK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 13, 2025, 8:00 PM EST - 5 weeks ago

Healthcare sector poised for rebound in 2025

JNJ LLY XLV

Jan 13, 2025, 6:10 PM EST - 5 weeks ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD IBB

Jan 13, 2025, 12:39 PM EST - 5 weeks ago

GSK CEO on acquisition of biotech firm IDRx

Jan 13, 2025, 12:07 PM EST - 5 weeks ago

Drugmakers rush to sign deals on first day of industry conference

ABBV ITCI JNJ LLY

Jan 13, 2025, 2:10 AM EST - 5 weeks ago

GSK to buy US biotech firm IDRx for up to $1.15 billion

Jan 13, 2025, 2:05 AM EST - 5 weeks ago

GSK Enters Agreement to Acquire IDRx, Inc.

Jan 7, 2025, 6:20 PM EST - 6 weeks ago

GSK and Pfizer's RSV vaccines to carry warnings of neurological disorder risk

PFE

Dec 20, 2024, 2:35 AM EST - 2 months ago

GSK's cancer drugs meet progression-free survival goal in late-stage trial

Dec 10, 2024, 7:00 AM EST - 2 months ago

Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis